Active Pharmaceutical Ingredients (API), popularly speaking, are the raw materials of medicines, only pharmaceutical raw materials are processed into pharmaceutical preparations , can they become medicines available for clinical use, so drugs we usually eat are the finished drugs through processing. Active Pharmaceutical Ingredients based on its sources can be divided into two major categories ,including chemical synthetic drugs and natural chemical drugs. Chemical synthetic drugs can be divided into organic synthetic drugs and inorganic synthetic drugs. Inorganic synthetic drugs are inorganic compounds ( very few is element), such as aluminum hydroxide, magnesium trisilicate which are used for the treatment of gastric and duodenal ulcers ; organic synthetic drugs are mainly composed of drugs made by basic organic chemical raw materials, through a series of organic chemical reactions (such as aspirin, chloramphenicol, caffeine, etc.). Natural chemical drugs ,based on its sources,can be divided into two categories including biochemical drugs and plant chemical drugs. Antibiotics are generally made by the microbial fermentation, which belongs to the biochemistry category. A variety of semi-synthetic antibiotics occurs in recent years,which are biosynthesis and chemical synthesis combining products.Among active Pharmaceutical Ingredients, the organic synthetic drugs varieties, yields and values have the largest proportion,which are the main pillars of the chemical and pharmaceutical industries. The quality of active Pharmaceutical Ingredients decides whether the formulation is good or bad , so its quality standards are very strict ,countries in the world have developed national pharmacopoeia standards and strict quality control methods for its widely used active Pharmaceutical ingredients.
Structural Characteristics and Structural Characteristics of Fucoxanthin
Fucoxanthin exhibits notable antitumor, anti?inflammatory, antioxidant, weight?reducing, and neuroprotective properties.
Feb 9,2026 API4-Phenylbutyric Acid: Physiological Functions & Therapeutic Potential
4-Phenylbutyric acid alleviates hepatic insulin resistance, protects islet β cells, and acts as an mRNA translation attenuator with therapeutic potential.
Feb 9,2026 APISynthesis and transformations of 9-Anthracenemethanol
In organic synthesis, 9-Anthracenemethanol serves primarily as a starting material for the preparation of organic luminescent materials.
Feb 9,2026 API4,5-Dicyanoimidazole: Synthesis Activation & Optoelectronic Applications
4,5-Dicyanoimidazole activates nucleoside phosphoramidites for oligonucleotide and serves as an acceptor unit for nonlinear optical push-pull molecules.
Feb 6,2026 APIStructural properties and Synthesis of 1-Bromo-4-chlorobutane
In organic synthesis, 1-bromo-4-chlorobutane is frequently employed as a bifunctional linear alkane precursor for 1,4-difunctionalization.
Feb 5,2026 APIPharmacological Action and Directions for Use of Besifloxacin hydrochloride
Besifloxacin Hydrochloride is a fourth generation fluoroquinolone antibiotic. Besifloxacin Hydrochloride is a DNA gyrase and topoisomerase IV inhibitor.
Feb 4,2026 APIPreparation Methods and Structural Characteristics of Hydrogenated bisphenol A (HBPA)
Hydrogenated bisphenol A (HBPA) is produced through the hydrogenation of bisphenol A. It is used as a raw material for synthesizing polyester resins.
Feb 3,2026 APISynthetic Methods and Diazotization reaction of 4-Amino-3,5-dichlorobenzotrifluoride
4-Amino-3,5-dichlorobenzotrifluoride has been documented in the literature as a key raw material for the preparation of the insecticide fipronil.
Feb 3,2026 APIClinical Study and Therapeutic Use of Indobufen
Indobufen is an orally active antiplatelet agent. Clinical trial data support the efficacy of indobufen in the secondary prevention of thromboembolic events.
Feb 3,2026 APIChemical Properties and Applications of Trifluoromethanesulfonyl chloride
Trifluoromethanesulfonyl chloride serves as an efficient sulfonating agent for alcohols, it also function as a chlorinating agent for carbanions.
Feb 3,2026 API








